Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Product Details
Alternative Name |
APO-1L, CD95L, CD178, TNFSF 6 |
---|---|
Application |
FUNC |
Application Notes |
Kills Fas-sensitive cells at concentrations of >1ng/ml in the presence of cross-linking enhancer. |
Concentration |
FasL: 0.1mg/ml after reconstitutionEnhancer: 1mg/ml |
Contents |
10µg of FasL, Soluble (human) (recombinant) (Prod. No. ALX-522-001) and 4×50µg of Enhancer for Ligands (Prod. No. ALX-804-034) which increases the biological activity (induction of apoptosis) by ~50-fold to a concentration range of 1-5ng/ml. |
Formulation |
FasL: Lyophilized. Contains PBS. |
Purity |
≥95% (SDS-PAGE) |
Reconstitution |
Reconstitute FasL with 100µl sterile water. Further dilutions should be made with medium containing 5% fetal calf serum or carrier protein. |
Source |
Produced in HEK 293 cells. The extracellular domain of human FasL (APO-1L; CD95L; CD178) (aa 103-281) is fused at the N-terminus to a linker peptide (26 aa) and a FLAG®-tag. Glycosylation of FasL, Soluble (human) (recombinant) is similar to natural human FasL. |
Specific Activity |
ED50: 1ng/ml (A20 cells) |
Specificity |
FasL binds to human, mouse and rat Fas (CD95). |
Technical Info / Product Notes |
FLAG is a registered trademark of Sigma-Aldrich Co. |
UniProt ID |
P48023 |
Handling & Storage
Use/Stability |
Stable for at least 6 months after receipt when stored at -20°C. |
---|---|
Handling |
Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and store at -20°C. |
Long Term Storage |
-20°C |
Shipping |
Blue Ice |
Regulatory Status |
RUO – Research Use Only |
---|
- Advanced multiparametric image spectroscopy and super-resolution microscopy reveal a minimal model of CD95 signal initiation: Bartels, N., van der Voort, N. T. M., et al.; Sci. Adv. 10, eadn3238 (2024), Abstract
- A Minimal Model of CD95 Signal Initiation Revealed by Advanced Super-resolution and Multiparametric Fluorescence Microscopy: Bartels, N., van der Voort, N. T. M., et al.; bioRxiv , (2022)
- The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer: R. Mandal, et al.; Cell. Mol. Life Sci. 79, 597 (2022), Abstract
- Caspase-8-Dependent Inflammatory Responses Are Controlled by Its Adaptor, FADD, and Necroptosis: Tummers, B., Mari, L., et al.; Immunity 52, 994 (2020), Abstract
- Amplification of CD95 activation by caspase 8-induced endosomal acidification in rat hepatocytes: R. Reinehr, et al.; J. Biol. Chem. 283, 2211 (2008), Abstract — Full Text
- Fas (CD95) induces macrophage proinflammatory chemokine production via a MyD88-dependent, caspase-independent pathway: W.A. Altemeier, et al.; J. Leukoc. Biol. 82, 721 (2007), Abstract — Full Text
- p21CIP1/WAF1 controls proliferation of activated/memory T cells and affects homeostasis and memory T cell responses: C.F. Arias, et al.; J. Immunol. 178, 2296 (2007), Abstract
- Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma: M. Guidoboni, et al.; Cancer Res. 65, 587 (2005), Abstract — Full Text
- CD1d-unrestricted human NKT cells release chemokines upon Fas engagement: M. Giroux and F. Denis; Blood 105, 703 (2005), Abstract — Full Text
- The role of p53 and Fas in a model of acute murine graft-versus-host disease: S. Yada, et al.; J. Immunol. 174, 1291 (2005), Abstract — Full Text
- Cutting edge: SDS-stable Fas microaggregates: an early event of Fas activation occurring with agonistic anti-Fas antibody but not with Fas ligand: P. Legembre, et al.; J. Immunol. 171, 5659 (2003), Abstract
- Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions: I. Viard-Leveugle, et al.; J. Biol. Chem. 278, 16183 (2003), Abstract — Full Text
- Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein: X.M. Sun, et al.; J. Biol. Chem. 277, 11345 (2002), Abstract — Full Text
- Induction of apoptosis in malignant pleural mesothelioma cells by activation of the Fas (Apo-1/CD95) death-signal pathway: J.H. 4th Stewart et al.; J. Thorac. Cardiovasc. Surg. 123, 295 (2002), Abstract
- An essential role for membrane rafts in the initiation of Fas/CD95-triggered cell death in mouse thymocytes: A.O. Hueber, et al.; EMBO Rep. 3, 190 (2002), Abstract — Full Text
- Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas: P. Legembre, et al.; Cell Death Differ. 9, 329 (2002), Abstract — Full Text
- Multiple pathways of TWEAK-induced cell death: M. Nakayama, et al.; J. Immunol. 168, 734 (2002), Abstract
- Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8: M.R. Sprick, et al.; EMBO J. 21, 4520 (2002), Abstract
- Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand: G. Lu, et al.; J. Immunol. 168, 1831 (2002), Abstract
- Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway: D. Vermijlen, et al.; J. Leukoc. Biol. 72, 668 (2002), Abstract
- NF-κB signals induce the expression of c-FLIP: O. Micheau, et al.; Mol. Cell. Biol. 21, 5299 (2001), Abstract — Full Text
- Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2: C.A. Benedict, et al.; J. Biol. Chem. 276, 3270 (2001), Abstract — Full Text
- Fas ligand-induced c-Jun kinase activation in lymphoid cells requires extensive receptor aggregation but is independent of DAXX, and Fas-mediated cell death does not involve DAXX, RIP, or RAIDD: A. Villunger, et al.; J. Immunol. 165, 1337 (2000), Abstract — Full Text
- Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in in: M. Rescigno, et al.; J. Exp. Med. 192, 1661 (2000), Abstract — Full Text
- Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L): D.C. Huang, et al.; PNAS 96, 14871 (1999), Abstract — Full Text
Related Products

Alternative Name | APO-1L, CD95L, CD178, TNFSF 6 |
---|---|
Purity | ≥95% (SDS-PAGE) |
Source | Produced in HEK 293 cells. The extracellular domain of human FasL (APO-1L; CD95L; CD178) (aa 103-281) is fused at the N-terminus to a linker peptide (26 aa) and a FLAG®-tag. Glycosylation of rhsFasL is similar to that of natural human FasL. |
Enhancer for Ligands
ALX-804-034
Enhances biological activity of TRAIL, soluble (human) (recombinant) and FasL, soluble (human) (recombinant).

Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form